TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
about
Trop2 and its overexpression in cancers: regulation and clinical/therapeutic implicationsCorrelation between Trop2 and amphiregulin coexpression and overall survival in gastric cancerTrop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.The cytosolic tail of the tumor marker protein Trop2--a structural switch triggered by phosphorylationPrognostic value of TROP2 in human nasopharyngeal carcinoma.Trop2 is overexpressed in gastric cancer and predicts poor prognosis.Trop2: from development to disease.Trop2 gene: a novel target for cervical cancer treatment.TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancerA critical question for cancer therapy: what new targets exist?TROP2 expression and its evolving role in tumor pathogenesis in systemic tumors.Prognostic role and clinical significance of trophoblast cell surface antigen 2 in various carcinomas.Trop2 regulates motility and lamellipodia formation in cultured fetal lung fibroblasts.Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.[The targets research of non-small cell lung cancer targeted therapy].The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target.Down-regulation of Predicts Poor Prognosis of Hepatocellular Carcinoma Patients
P2860
Q27004380-79ECA01F-F254-4AEE-8E89-4885552CE54FQ33679575-23D600A8-5D46-4FC6-892E-18794854B231Q33909333-97B9904C-6217-4253-86A8-4B5C30EB3E7AQ34097528-AB8C640D-58A1-44CC-9274-F75993EF64EAQ34476583-6881E7E4-E627-4890-9FCF-16E67CBA180FQ34619329-A24E3C16-6E5D-4CD5-9081-9016253837A5Q35616726-1453CF01-978F-4A78-9633-0F4306DEE53BQ36261589-36625C6A-1032-4B67-8163-B602C652401CQ36905863-6BB1D102-2BFA-4387-8A2E-B3D776B71336Q38293559-1D343DD6-760E-4831-B888-05F379406081Q38996163-9C503AE7-A3C8-4336-8B72-7FF93D4DCF65Q41470890-8BFBC1C6-87B3-475A-BF4F-8738711630FDQ41709315-3911120D-931D-43D8-9133-F06B3DFEBD8FQ41940514-8531A4E3-811D-4B05-B0E5-BC14821E3110Q46308742-D6EA8458-1731-4881-95B0-D1F0032987B5Q47147021-42DF2682-26C2-448D-A487-15DE0CF500C2Q47917074-4C915BD0-8CCA-46F1-A759-A7B4C9218EB1Q52655967-2903DFCB-E2D8-467E-8317-1A7E831A560CQ55434033-70CD6F63-8F92-4A9A-8480-57591FCDA62FQ55508847-BF7A4DAD-9454-4D1A-870A-BF69B62816B2Q58587194-709A9FD9-6AAB-44B0-BC02-831550195A68
P2860
TROP2 is epigenetically inactivated and modulates IGF-1R signalling in lung adenocarcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@ast
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@en
type
label
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@ast
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@en
prefLabel
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@ast
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@en
P2093
P2860
P356
P1476
TROP2 is epigenetically inacti ...... alling in lung adenocarcinoma.
@en
P2093
Chen-Tu Wu
Jau-Chen Lin
Jing-Yi Wu
Pan-Chyr Yang
Tse-Ming Hong
Tzu-Chieh Lin
Yi-Ying Wu
Yih-Leong Chang
Yuh-Shan Jou
P2860
P304
P356
10.1002/EMMM.201200222
P577
2012-03-15T00:00:00Z